http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008220080-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97f8939cf76e68731c5704c708ac7a89 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
filingDate | 2006-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9f7236752361cb562301fc99dc6d0f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e953f513486dc67bf20727578eb490d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_603722c1e854884a81d2a914d73e4b26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cd331134461a7716ede4228f2a0c47f |
publicationDate | 2008-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2008220080-A1 |
titleOfInvention | Multiparticulate Pharmaceutical form Comprising Pellets with a Substance Having a Modular Effect in Relation to Active Ingredient Release |
abstract | The invention relates to a multiparticulate pharmaceutical form, comprising pellets with a multilayer structure for controlled active ingredient release, comprising a) a core layer comprising a substance having a modulating effect, b) an inner controlling layer which influences the delivery of the substance having a modulating effect, consisting of pharmaceutically usable polymers, waxes, resins and/or proteins, c) an active ingredient layer comprising an active pharmaceutical ingredient and, where appropriate, a substance having a modulating effect, d) an outer controlling layer comprising at least 60% by weight of one or a mixture of a plurality of (meth)acrylate copolymers where the layers may additionally and in a manner known per se comprise pharmaceutically usual excipients, where the outer controlling layer d) has a thickness from 20 to less than 55 μm and contains 0.1 to 10% by weight of glycerol monostearate, where the multiparticulate pharmaceutical form contains 20 to 60% by weight of the pellets, which are compressed in mixture with 80 to 40% by weight of an outer phase which consists from 50 to 100% by weight of a cellulose or a derivate of cellulose and optionally 0 to 50% by weight of further pharmaceutical excipients. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010071320-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9492394-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011082426-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101004205-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012093926-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009263478-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010291202-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9011907-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114796155-A |
priorityDate | 2005-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 2657.